Advanced search
Publication Cover
Leukemia & Lymphoma Volume 43, 2002 - Issue 8
Submit an article Journal homepage
401
Views
48
CrossRef citations to date
0
Altmetric
Research Article

FLT3 in Human Hematologic Malignancies

Hitoshi Kiyoi Department of Infectious Diseases, Nagoya University School of Medicine, 65 Tsurumai-cho, Showka-ku, Nagoya 466-8560, Japan
&
Tomoki Naoe Department of Infectious Diseases, Nagoya University School of Medicine, 65 Tsurumai-cho, Showka-ku, Nagoya 466-8560, Japan
Pages 1541-1547 | Published online: 01 Jul 2009

  • Rosnet, O., Marchetto, S., deLupeyriere, O. and Birnbaum, D. (1991) "Murine Flt3. a gene encoding a novel tyrosine kinase receptor of the PDGFR/CSF1R family". Oncogene 6, 1641-1650.
  • Rosnet, O., Schiff, C., Pehusque, M.J., Marchetto, S. Tonnelle. C, Toiron. Y., Birg, K and Bimbaum, D. (1995) "Human FLT3/FLK2 gene: cDNA cloning and expression in hemalopoietic cells". Blood 82, 1110-1119.
  • Lyman, S.D., James, L., Zappone, J., Sleath, K.R. Beckmann, M.P. and Bird. T. (1993) "Characterization of the protein encoded by the flt3 (flk2) receptor-like tyrosinc kinasc gene". Oncogene 8. 815-822.
  • Matthews, W., Jordan, C.T., Wiegand, G.W., Pardoll, D. and Lemischka, I.R. (1991) "A receptor tyrosine kinase spueitic to hematopoietic stem and progenitor cell-enriched populations". Cell 65.1143-1152.
  • Rohertson, S.C., Tynan, J. and Donoghue, D.J. (2000) "RTK mutations and human syndromes: when good receptors turn had". Trends Genet. 16, 265-272
  • Boissan, M., Feger, R. Guillosson, J.J. and Arock, M. (20000 "C Kit and c-kit mutations in mastocytosis and other hematological diseases". J. Leukoc. Biol. 67, 135-148.
  • Rosnet, O., Buhring, H.J., del.apeyriere, O., Beslu, N., Lavagna, C., Marchetto, S., Rappold, I., Drexler, H.G., Birg. F., Rottapel, R., Hannum, C., Duhreuil, P. and Birobaum, D. (1996) "Expression and signal transduction of the FLT3 tyrosine kinasc receptor". Acta Haematol. 95, 218-223.
  • Hatimum, C, Culpepper, J., Campbell, D., McClanahan, T. Zurawski, S., Bazan, J.K, Kastelein, R., Hudak, S., Wagner, J., Mattson, J., Luh, J., Duda, G., Martina, N., Peterson, D., Menon, S. Shariafelt, A., Muench, M., Keiner, G., Namikawa, R., Rennick, D., Roncarolo, M., Zlofnik, A., Rosnet, O., Dubreuil, O., Birnbaum, D. and Lee, F. (1994) "Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs". Nature 368, 643-648.
  • McKenna, H.J., Smith, F.O., Hrasel, K., Hirschstein, D., Bernstein. I.D. Williams. D.E. and Lyman, S.D. (1996) "Effects of flt3 ligand on acute myeloid and lymphocytic leukemic blast cells from children". Exp. Hematol. 24, 378-385.
  • Rusten, L.S., Lyman, S.D., Veiby, O.P. and Jacobsen, S.E. (1996) "The FLT3 ligand is a direct and potent stimulator of the growth of primitive and committed human CD34 + hone marrow progenitor cells in vitro". Blood. 1317-1325.
  • Lyman, S.D. (1995) "Biology of flt3 ligand and receptor". Int. J. Hematol. 62, 63-73.
  • Lyman, S.D. and Jacobsen, S.E. (1998) "c-kit Ligand and Flt3 ligand: stem/progeentor cell factors with overlapping yet distinct activities". Blood. 1101-1134.
  • Dehmel, U., Quentmeier, H. and Drexler, H.G. (1996) "Effects of FLT3 ligand on human leukemia cells. II. Agonistic and antagonistic effects of other cytokines". Leukemia 10, 271-278.
  • DaSilva, N., Hu, Z.B., Ma, W., Rosnet, O., Birnbaum, D. and Drexler, H.G. (1994) "Expression of the FLT3 gene in human leukemia-lymphoma cell lines", leukemia 8, 885-8488.
  • Dehmel, U., Zaborski, M., Meierhoff, G., Rosnel, O., Birnbaum, D., Ludwig, W.D., Quentmeier, H. and Drexler, H.G. (1996) "Effects of FLT3 ligand on human leukemia cells I. Proliferative response of inyeloid leukemia cells". Leukemia 10. 261-270.
  • Drexler, H.G (1996) "Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells", leukemia 10, 588-599.
  • Drexler, H.G., Meyer, C. and Quentoneier, H. (1999) "Effects of FLT3 ligand on proliferation and survival of myeloid leukemia cells". Leuk. Lymphoma 33, 83-91.
  • Rosnet, O., Buhring, H.J., Marchetto, S., Rappold, I., Lavagna, C., Sainty, D., Amoulet, C., Chabannou, C., Kanz, I., Hannum, C. and Bimbaumm D. (1996) "Human FLT3/FLK2 receptor tyrosinc kinase is expressed at the surface of normal and malignant hematopoictic cells". Leukemia 10m 238-248.
  • Nakao, M. Yokota, S., Iwai, T., Kaneko, H., Honike, S, Kashima. K. Sonoda, Y., Fujimoto. T. and Misawa. S. (1996) "Internal andem duplication of the flt3 gene found in acute myeloid leukemia", leukemia 10, 1911-1918.
  • Yokota, S., Kiyoi, H., Nakao M., Iwai, T., Misawa, S., Okuda, T., Sonoda, Y., Abe, T., Kahsima, K., Matiuo, Y. and Naoe, T. (1997) "Internal tandem duplication of the FLT3 gene is preferentially seen in acute myeloid leukemia and myelodysplastic syndrome among various hematological malignancies. A study on a large series of patients and cell lines". Leukemia 11. 1605- 1699
  • Yamamoto, Y. Kiyoi, H., Nakano, Y. Suzuki. R., Kodera, Y. Mjyawaki, S., Asou.,N., Kuriyaiina. K. Yagasaki, F. Shimazaki, C. Akiyania. H., Saito, K., Nishimura, M. Motoji, T., Shinagawa, K, Takeshita, A., Saito, H., Ueda, R., Ohno, R. and Naoe, T. (2001) "Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies", Blood 97, 2434-2439.
  • Matsuo, Y. MacLeod, R.A., Uphoff, C.C., Drexler, H.G., Nishizaki. C. Katayama, Y., Kimura, G., Fujii, N., Omoto, H., Harada, M. and Orita, K. (1997) "Two acute monocytic leukemia (AML-M5a) cell lines (MOLM-13 and MOLM-14) with interclonal phenotypic heterogeneity showing MLL-AF9 fusion resulting from an occult chromosome insertion, ins(11:9)(q23;p22p23)". leukemia 11. 1469-1477.
  • Xu, F., Taki, T., Yang, H.W., Hanada, R., Hongo, T. Ohmshi, H., Kohayashi, M., Bessho, R. Yanagisawa, M. and Hayashi. Y. (1999) "Tandem duplication of the FLT3 gene is found in acute lymphoblastic leukaemia as well as acute myeloid leukaemia but not in myelodysplastic syndrome or juvenile chronic myelogenous leukaemia in children". Br. J. Haematol. 105. 155-162.
  • Kiyoi, H., Naoe, T., Yokota, S. Nakao, M., Minaini, S., Kuriyama. K. Takeshita, A., Saito, K., Hasegawa, S., Sbimodaira, S., Tamura. J., Shimazaki, C., Matsue, K., Kobayashi, H., Arima, N., Suzuki, R., Morishita, H., Saito, H., Ueda, R. and Ohno, R. (1997) "Internal tandem duplication of FLT3 associated with leukocytosis in acute promyelocytic leukemia. Leukemia Study Group of the Ministry of Health and Welfare (Kohseisbo)", Luukemia 11. 1447-1452.
  • Kiyoi, H., Naoe, T., Nakano, Y. Yokola, S., Miuami, S., Miyawaki. S., Asou, N., Kuriyama, K., Jinnai, I., Shimazaki, C., Akiyania, H., Saito, K., Oh, H., Motoji, X. Omoto, E., Saito, H., Ohno, R. aid Ueda, R. (1999) "Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia". Blood 93, 3074-3080.
  • Horiike, S., Yokota, S., Nakao, M., Ivrai, T., Sasai, Y, Kaneko, H., Taniwaki, M., Kashima, K., Fujii, H., Abe, T. and Misawa, S. (1997) 'Tandem duplications of the FLT3 receptor gene are associated with leukemic transformation of myelodysplasia". Leukemia 11. 1442-1446.
  • Roinbouts, W.J., Blokland, I., Lowenberg, B. and Ploemacher, R.E. (2000) "Biological characteristics and prognosis of adult acute myeloid leukemia with internal tandein duplications in the flt3 gene". Leukemia 14, 675-683.
  • Abu-Duhier, E.M., Goodeve, A.C., Wilson, G.A., Gari. M.M., Peake. I.R., Rees, D.C., Vandenberghe, E.A., Winship, P.R. and Reilly. I.T. (2000) "FLT3 internal tandem duplication mutations in adult acute myeloid leukaemia dehne a high-risk group". Br J. Huematol. 111, 190-195.
  • Fenski, R., Flesch, K., Serve, S., Mizuki, M., Oelmann, E., KrauAIbers, K., Kienast, J., Leo, R., Schwartz, S., Berdel, W.E. and Serve. H. (2000) "Constitutive activation of FLT3 in acute myeloid leukaemia and its consequences for growth of 32D cells". Br. J. Haematol. 108, 322-330.
  • Kottaridis, P.D., Gale, R.F., Frew, M.L., Harrison, G., Langabecr. S.E, Belton, A.A., Walker. H., WheatIey, K., Bowen, D.T., Buunett, A.K. Goldstone, A.M. and Linch. D.C. (2001) 'The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AMD adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials". Blood 98, 1752-1759.
  • Stirewalt D.L., Kopetky, K.J, Meshinchi, S., Appelhaum, F.R., Slovak. M.L., Williman, C.L. and Radich, J.P. (2001) "FLT3, RAS and TP53 mutations in elderly patients with acute myeloid leukemia". Blood 97. 3589-3595.
  • Whitman, S.P., Archer, K.J., Feng, L, Baldus, C. Becknell, B., Carlson, B.D., Carroll. A.J., Mrozek, K,. Vardiman, J.W. George. S.L. Kolitz, J.E., Larson, R.A., Bloomfield. C.D. and Caligiuri, MA. (2001) "Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B study". Cancer Res. 61, 7233-7239.
  • Iwai, T. Yokota, S., Nakao, M., Okamoto, T., Taniwaki, M., Onodera, N. Watanabe, A., Kikuta, A., Tanaka, A., Asami, K. Sekiiie, I., Mugishima, H., Nishimura, Y., Koizuini, S., Horikoshi. Y., Mimaya, J., Ohta, S., Nishikawa, K., Iwai, A., Shirookawa, T., Nakayama, M., Kawakumi, K., Gushiken, T., Hyakuna, N., Katano. N., Tsurusawa, M. and Fujimoto, T (1999) "Internal tandem duplication of the FLT3 gene and clinical evaluation in childhood acute myeloid leukemia. The Children's Cancer and Leukemia Study Group. Japan". Leukemia 13, 38-43.
  • Kondo, M., Horibe, K., Takahashi, Y., Matsumoio, K., Fukuda, M., lnaba, J., Kalo, K., Kojima, S. and Matsuyama, T. (1999.) "Prognustic value of internal tandem duplication of the FLT3 gene in childhood acute myelogenous leukemia", Med. Pediatr. Oncol. 33, 525-529.
  • Meshinchi, S., Woods, W.G., Stirewalt, D.L. Sweetser, D.A., Buckley, J.D., Tjoa, T.K. Bernstein. I.D. and Radich, J.P. (2001) "prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute myeloid leukemia". Blood 97, 89-94.
  • Kiyoi, H., Towatari, M., Yokota, S., Hamuguchi, M., Ohno, R., Saito. H. and Naoe, T. (1998) "Internal tandem duplication of the FLT3 gene is a novel modality of elongation mutation which causes constitutive activation of the product", Leukemia 12, 1333-1337.
  • Trinh. T.Q. and Sinden, R.R. (1991) "Preferential DNA secondary structure inutagenesis in the lagging strand of replication in E. cnli". Nature 352. 544-547.
  • Lovett, S.T. and Fesebenko. V.V. (1996) "Stabilization of diverged tandem repeats by mismatch repair: evidence fur deletion formation via a misaligned replication intermediate", Proc. Natl Acad. Sci. USA 93, 7120-7124.
  • Furitsu, T. Tsujimura, T., Tono, T., lkeda, H., Kitayama, H., Koshimizu, U., Sugahara, H., Buttertield, J.H., Ashman, L.K., Kanayama, Y. Matsuzawa, Y., Kitamuru, Y. and Kanakura, Y. (1993) "Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product", J. Clin. lnvesting. 92, 1736-1744.
  • Beghini, A., Peterlongo, P., Ripamonti, C.B. Larizza, I., Cairoli. R. Morra, K. and Mecucci, C. (2000) "C-kit mutations in core binding factor leukemias". Blood 95, 726-727.
  • Weiss, A. and Schlessinger, J. (1998) "Switching signals on or off by receptor dinerization". Cell 94, 277-280.
  • Morley, G.M., Uden, M., Gullick, W.J. and Dibb, N.J. (1999) "Cell specific transformation by c-fms activating lpop mutations is attributable to constitutive receptor degradation". Oncogene 18. 3076-3084.
  • Bloomfield, C.D., Shuma, C., Regal, L., Philip, P.P., Hossfeld. D.K., Hagemeijer, A.M., Carton, O.M., Peterson, B.A., Sakurai, M., Alimena, G., Berger. R., Rowley, J.D., Ruutu, T., Milelman, F., Dewald, G.W. and Swansbury, J. (1997) "Long-term survival of patients with acute myeloid leukemia: a third follow-up of the Fourth International workshop on chromosomes in leukemia". Cancer 80, 2191-2198.
  • Radich, J.P., Kopecky, K.J., Willmaan, C.I. Weick, J., Head, D., Appelbaum, F. and Collins. S.J. (1990) "N-ras mutations in adult de nova acute myelugenous leukemia: prevalence and clinical significance". Bloodt 76. 801 807.
  • Neubauer. A., Dodge, R.K., George, S.L., Davey, F.R., Silver, R.T., Schiffer, C.A., Mayer, R.J., Ball, E.D., Wurster-Hill, D. Bloomfeild, C.D., et al., (1994) "Prognostic importance of mutations in the ras proto-oncogenes in de novo acute myeloid leukemia", Blood 83, 1603-1611.
  • Kubo, K., Naoe, T., Kiyoi, H., Fukutani, H., Kalo, Y. Oguri, T., Yamainori, S., Akatsuka, Y. Kodera, Y. and Ohno, R. (1993) "Clonal analysis of multiple point mutations in the N-ras gene in patients with acute myeloid leukemia". Jpn J. Cancer Res. 84, 370-387.
  • Fenaux, P. Jonveaux, P., Quiquandon, l., Lai, J.L., Pignon, J.M., Loucheux-Lefebvre, M.H. Bauters, F., Berger, R. and Kerckaert. J.P. (1991 )"P53 gene mutations in acute myeloid leukemia with 17p monosoiny". Blood. 1652-1657.
  • Parry, T.E. (1997) 'The mm-random distribution of point mutations in leukaemia and myelodysplaxiu-a possible pointer to their aetiology". Leuk. Res 21, 559-574.
  • Wattel, E., Preudhomme, C., Hecquet, B. Vanrumbeke, M., Quesnel, B., Dervite, I., Morel, P. and Fenaux P. (1994) "p53 Mutations are associated with resistance to chemotherapy and short survival in hematologie malignancies", Blood. 3148-3157.
  • Xu, K, Taki, T., Eguchi, M., Kamada, N., lshii, E., Endo, M. and Hayashi, Y (2000) "Tandem duplication of the FLT3 gene is infrequent in infant acute leukemia. Japan Infant Leukemia Study Group". Leukemia 14, 945-947.
  • Nakano, Y. Kiyoi. H., Miyawaki. S-. Asou. N., Ohno, R., Saito, H. and Naoc, T. (1999) 'Molecular evolution of acute myeloid leukaemia in relapse: unstable N-ras and FLT3 genes compared with p53 gene", Br. Haematol 104, 659-664.
  • Zhao, M., Kiyoi, H., Yamamoto, Y. ito, M., Towatari, M., Omura. S., Kitamura, T., Ueda, R. Saito, H. and Naoe. T. (2000) 'in vivo treatment of mutant FLT3-transfortned murione leukemia with a tyrosme kinase inhibitor". Leukemia 14, 374-378.
  • Hayukawa, F., Towatari, M., Kiyoi, H., Tanimoto, M., Kitamura, T. Saito, H. and Naoe. T. (2000) "Tandem-duplicated Flt3 constitutively activates STATS and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines". Oncogene 19. 624 -631.
  • Mizuki, M., Fenski, R., Halfter, H., Matsuinurm, I., Schmidt, R. Muller, C. Grading, W., Kratz-Albers, K., Serve, S., Steur, C., Buchner, T. Kienast, J., Kanakura, Y. Berdel, W.K. and Serve. H.(2000) "Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STATS pathways". Blood 96, 3907-3914.
  • Kiyoi. H., Ohno, R., Ueda, R., Saito. H. and Naoe. T. (2002) "Mechanism of constitutive activation of FI-T3 with internal tandem duplication in the juxtamembrane domain", Oncogene. In press.
  • Kelly, L.M., Liu. Q., Kutok. J.L., Williams, I.R., Boulton. C.L. and Gilliland, D.G. (2002) "FLT3 internal tandem duplication mutations associated with human acute myeloid leukemias induce myeloproliferative disease in a murine bone marrow transplant model". Blood 99, 310-318.
  • Druker, B.J., Talpaz. M., Resta, D.J., Peng, B., Buchdunger, E., Ford, J.M., Lydon, N.B., Kantarjian, H., Capdeville, R., OhnoJones, S. and Sawyers, C.L. (2001) "Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia". N. Engl J. Med 344, 1031-1037.
  • Huang, M.E., Ye. Y.C., Chen, S.R., Chai, J.R., Lu, J.X., Zhoa, L., Gu, L.J. and Wang. Z.Y. (1988) "Use of all- trans retinoic acid in the treatment of acute promyelocytic leukemia". Bloodt 72, 567-572.
  • Buchner, J. (1999) Hsp90 and Co.-a holding for folding". Trends Biochem. Sci. 24, 136-141.
  • Mnyer, M.P. and Bukau, B. (1999) "Molecular chaperones: the busy life of Hsp90". Curr. Biol 9, 322-325.
  • Naoe, T., Kiyoi, H., Yamamoto, Y. Minami, Y., Yamamoto, K., Ueda, R. and Saito, H. (2001) "FLT3 tyrosine kinase as a target molecule for selective antileukemia therapy". Cancer Chemother: Pharmacol. 48(Suppl. 1). S27- S30.
  • Tse, K.F., Novelli. E., Civin, C.I., Bohmer, F.D. and Small, D. (2001) "Inhibition of FLT3-mediated transformation by use of a tyrosine kinase inhibitor", leukemia 15, 1001-1010.
  • Levis, M., Tse, K.F., Smith, B.D., Garrett, E. and Small. D. (2001) "A FLT3 tyrosine kinase inhibitor is selectively cytotoxic to acute myeloid leukemia blasts harboring FLT3 internal tandem duplication mutations". Blood 98, 885-887.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.